Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > Cancer Res Treat > Volume 49(2); 2017 > Article
Meta-Analysis Alcohol Intake and Risk of Thyroid Cancer: A Meta-Analysis of Observational Studies
Seung-Hee Hong, PhD1, Seung-Kwon Myung, MD, PhD2,3,4,, Hyeon Suk Kim, PhD5, The Korean Meta-Analysis (KORMA) Study Group
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2017;49(2):534-547.
DOI: https://doi.org/10.4143/crt.2016.161
Published online: July 7, 2016

1Division of Food Science and Culinary Arts, Food and Nutrition Major, Shinhan University, Uijeongbu, Korea

2Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

3Molecular Epidemiology Branch, Division of Cancer Epidemiology and Prevention, Research Institute, National Cancer Center, Goyang, Korea

4Department of Family Medicine, Center for Cancer Prevention and Detection, Hospital, National Cancer Center, Goyang, Korea

5School of Nursing, Shinhan University, Uijeongbu, Korea

Correspondence: Seung-Kwon Myung, MD, PhD, Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea
Tel: 82-31-920-0479 Fax: 82-31-920-2606 E-mail: msk@ncc.re.kr
• Received: May 4, 2016   • Accepted: June 19, 2016

Copyright © 2017 by the Korean Cancer Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 13,178 Views
  • 312 Download
  • 39 Web of Science
  • 40 Crossref
  • 41 Scopus
prev next
  • Purpose
    The purpose of this study was to assess whether alcohol intake is associated with the risk of thyroid cancer by a meta-analysis of observational studies.
  • Materials and Methods
    We searched PubMed and EMBASE in June of 2015 to locate eligible studies. We included observational studies such as cross-sectional studies, case-control studies, and cohort studies reporting odd ratios (ORs) or relative risk (RRs) with 95% confidence intervals (CIs).
  • Results
    We included 33 observational studies with two cross-sectional studies, 20 case-controls studies, and 11 cohort studies, which involved a total of 7,725 thyroid cancer patients and 3,113,679 participants without thyroid cancer in the final analysis. In the fixed-effect model meta-analysis of all 33 studies, we found that alcohol intake was consistently associated with a decreased risk of thyroid cancer (OR or RR, 0.74; 95% CI, 0.67 to 0.83; I2=38.6%). In the subgroup meta-analysis by type of study, alcohol intake also decreased the risk of thyroid cancer in both case-control studies (OR, 0.77; 95% CI, 0.65 to 0.92; I2=29.5%; n=20) and cohort studies (RR, 0.70; 95% CI, 0.60 to 0.82; I2=0%; n=11). Moreover, subgroup meta-analyses by type of thyroid cancer, gender, amount of alcohol consumed, and methodological quality of study showed that alcohol intake was significantly associated with a decreased risk of thyroid cancer.
  • Conclusion
    The current meta-analysis of observational studies found that, unlike most of other types of cancer, alcohol intake decreased the risk of thyroid cancer.
According to the World Cancer Report 2014 published by the World Health Organization’s International Agency for Research on Cancer, thyroid cancer is among the less frequent malignancies, being ranked eighth in world cancer incidence based on major organs affected by cancer for women [1]. However, its incidence has rapidly increased, nearly doubling during the past decade [2,3]. While the reasons for this increase remain unclear, it has been reported that it could be due to more sensitive diagnostic tools and frequent screenings for thyroid cancer using thyroid ultrasound [3,4].
Overall, the causes of thyroid cancer are not fully established. The only proven risk factor for developing thyroid cancer is exposure to radiation, particularly in childhood [5,6]. Possible risk factors are a history of benign thyroid nodules/adenoma or goiter, iodine intake, obesity, smoking, and alcohol consumption [7-9]. Among these risk factors, smoking is a well-known risk factor for developing most cancers. However, a recent meta-analysis of 31 observational studies reported that smoking is associated with a decreased risk of thyroid cancer [10].
Moreover, previous observational studies have reported an association between alcohol intake and the risk of thyroid cancer. However, those findings remain inconsistent. In 2003, a pooled analysis of 14 case-control studies found that there was a significant trend of reduced thyroid cancer risk that was not found after adjustment for smoking [11], whereas a pooled analysis of five prospective cohort studies published in 2012 reported an inverse association between alcohol consumption and risk of thyroid cancer [12].
The current study was conducted to investigate the association between alcohol intake and risk of thyroid cancer using a meta-analysis of observational studies such as cross-sectional, case-control and cohort studies.
1. Literature search
We searched PubMed (1970 to May 2015) and EMBASE (1987 to May 2015) for eligible studies using common keywords related to alcohol intake and the risk of thyroid cancer. The keywords for literature search were as follows: “alcohol,” “thyroid cancer,” and “cross-sectional study,” “casecontrol study,” or “cohort study.”
2. Selection criteria
We included observational studies such as case-control studies and prospective or retrospective cohort studies that investigated the association between alcohol intake and the risk of thyroid cancer, reporting outcome measures with adjusted odds ratios (ORs) or relative risk (RRs) and 95% confidence intervals (CIs). If data were duplicated or shared in more than one study, the first published study or most comprehensive study was included in the analysis. The language of publication was restricted to English.
3. Selection of relevant studies
Two of the authors (S.-H.H. and H.S.K.) independently evaluated the eligibility of all studies retrieved from the databases based on the pre-determined selection criteria. Disagreements between evaluators were resolved by discussion. We extracted the following data from studies included in the final analysis: study name (along with the name of the first author and year of publication), type of study design, country, study period (years), population (age, sex), definitions of alcohol use (highest vs. lowest category), OR/RR with 95% CI, and adjustments of variables.
4. Assessment of methodological quality
We assessed the methodological quality of included studies based on the Newcastle-Ottawa Scale (NOS) for assessing the quality of case-control studies and cohort studies in meta-analyses [13]. The star system of the NOS ranged from 0 to 9 and consisted of three subscales: selection of studies, comparability, and exposure. In the current study, we considered a study awarded more than a mean score of each study type to be a high-quality study because criteria for quality of a study have not been established. Two pooled studies [11,12] with 14 case-control studies, five cohort studies and a cross-sectional study were excluded from this assessment of methodological quality because no required information for the methodological assessment of each study was provided.
5. Main and subgroup analyses
We investigated the association between alcohol intake (highest use vs. lowest use) and risk of thyroid cancer using adjusted ORs or RRs with 95% CIs for the main analysis. We also performed subgroup analyses based on type of thyroid cancer, gender, region of study population (America, Asia, and Europe), amount of alcohol consumed, type of alcohol, methodological quality, and type of study design (case-control or cohort studies).
6. Statistical analyses
To calculate a pooled OR or RR with 95% CI, we used adjusted ORs or RRs and 95% CIs reported in individual articles whenever possible. We evaluated heterogeneity in results across studies using Higgins, which measures the percentage of total variation across studies [14]. I2 was calculated as follows:
  • I2=100%×(Q–df)/Q,

where, Q is Cochran’s heterogeneity statistic and df is the degrees of freedom. Negative values of I2 are set at zero; I2 lies between 0% (no observed heterogeneity) and 100% (maximal heterogeneity). An I2 value greater than 50% was considered to indicate substantial heterogeneity.
When substantial heterogeneity was not observed, the pooled estimate calculated based on the Fixed-effect model was reported using Woolf’s method (inverse variance method). When substantial heterogeneity was observed, the pooled estimate calculated based on the random-effects model was reported using the DerSimonian and Laird method [15].
We also examined publication bias regarding the studies included in the final analysis using Begg’s funnel plot and Egger’s test. If publication bias exists, the Begg’s funnel plot is asymmetrical or the p-value is less than 0.05 by Egger’s test. Statistical analyses were conducted using the Stata SE ver. 12.1 software package (StataCorp., College Station, TX).
1. Identification of relevant studies
Fig. 1 shows a flow diagram of how relevant studies were identified. A total of 213 articles were identified by searching PubMed and EMBASE. We excluded 28 duplicated articles and an additional 140 articles that did not satisfy the selection criteria. The full texts of the remaining 45 articles were reviewed, and 29 additional articles were for the reasons shown in Fig. 1. The remaining 16 articles [11,12,16-29] were included in the final analysis.
2. General characteristics of studies
We identified a total of 33 observational studies with two cross-sectional studies, 20 case-control studies, and 11 cohort studies from 16 articles, which included 7,725 thyroid cancer patients among 3,113,679 participants. Table 1 shows the general characteristics of the studies in the final analysis. The included studies were performed in the United States (n=15), Sweden (n=3), Japan (n=3), Korea (n=2), Norway (n=2), Canada (n=1), French Polynesia (n=1), Greece (n=1), Italy (n=1), New Caledonia (n=1), Switzerland (n=1), and the United Kingdom (n=1). The mean age was 48.5 years (range, 10 to 89 years), and 74% of the study participants were women. The enrolment period for participants across studies ranged between 1964 and 2013, and the follow-up periods in the cohort studies ranged from 7.2 to 23 years.
3. Alcohol intake and risk of thyroid cancer
Fig. 2 shows the effect of alcohol intake on the risk of thyroid cancer in the meta-analysis of all studies. Alcohol intake (highest vs. lowest intake) was significantly associated with decreased risk of thyroid cancer in a fixed-effect model meta-analysis of all 33 observational studies (OR or RR, 0.74; 95% CI, 0.67 to 0.83; I2=38.6%). As shown in Fig. 3, in the subgroup meta-analysis by type of study, alcohol intake also decreased the risk of thyroid cancer in both case-control studies (OR, 0.77; 95% CI, 0.65 to 0.92; I2=29.5%; n=20) and cohort studies (RR, 0.70; 95% CI, 0.60 to 0.82; I2=0%; n=11), but not in cross-sectional studies (OR, 0.82; 95% CI, 0.62 to 1.09; I2=91.3%; n=2). There was no publication bias in the 33 studies (Begg’s funnel plot was symmetric; Egger’s test, p for bias=0.97) (Fig. 4).
4. Methodological quality of studies
Table 2 shows the methodological quality of studies included in the final analysis based on the NOS. The quality scores ranged from 4 to 9, with an average score of 6.3 for case-control studies and 6.5 for cohort studies. The high-quality studies (score of 7 or higher) included two case-control studies and three cohort studies.
5. Subgroup meta-analyses
Table 3 summarizes the results from the subgroup meta-analyses based on several factors. In the subgroup meta-analyses by type of thyroid cancer, sex, and amount of alcohol consumed, alcohol intake was significantly associated with a decreased risk of thyroid cancer. The subgroup meta-analyses by geographic region showed that alcohol intake was associated with a decreased risk of thyroid cancer in the American region (OR or RR, 0.70; 95% CI, 0.60 to 0.81; I2=0%; n=12), but not in the European (OR or RR, 0.60; 95% CI, 0.36 to 1.00; I2=13.1%; n=2) or Asian regions (OR or RR, 0.82; 95% CI, 0.48 to 1.42; I2=76.3%; n=4).
Moreover, subgroup meta-analyses by methodological quality of study indicated that alcohol intake decreased the risk of thyroid cancer in both high-quality studies (OR or RR, 0.64; 95% CI, 0.50 to 0.82; I2=0%; n=5) and low quality studies (OR or RR, 0.68; 95% CI, 0.55 to 0.85; I2=6.7%; n=7).
Tables 4 and 5 show the findings from the subgroup meta-analyses based on various factors within each study design (case-control study and cohort study). Overall, subgroup meta-analyses of cohort studies by various factors indicated that alcohol intake significantly decreased the risk of thyroid cancer, whereas those of case-control studies indicated that alcohol intake decreased the risk of thyroid cancer, although this decrease was not statistically significant.
1. Summary of the main findings
In this meta-analysis, we found that there was an inverse association between alcohol intake and the risk of thyroid cancer. Moreover, overall, alcohol intake was associated with a decreased risk of thyroid cancer in the subgroup meta-analyses by type of thyroid cancer, sex, amount of drink, and methodological quality of study. In the subgroup meta-analyses by various factors within each study design, alcohol intake consistently showed a significantly decreased risk of thyroid cancer in both case-control and cohort studies, but a non-significantly decreased risk in cross-sectional studies.
2. Possible biological mechanisms responsible for the main findings
There are several biological mechanisms that may explain the inverse association between alcohol intake and the risk of thyroid cancer observed in our meta-analysis. First, alcohol intake may have a protective effect on developing thyroid cancer by decreased levels of thyroid-stimulating hormone (TSH). TSH made by the pituitary gland is a well-established growth factor for thyroid nodules, and it is known that higher serum TSH levels are associated with higher rates of thyroid cancer [30]. An animal study demonstrated that chronic alcohol exposure reduces the responsiveness of the hypo-thalamic-pituitary-thyroid axis to central stimulation [31]. Moreover, many cross-sectional and longitudinal studies have reported that a blunting of the plasma TSH response in the thyrotropin releasing hormone stimulation test was consistently observed in patients of alcohol dependence compared to healthy people [32]. Another biological mechanism is that alcohol has a direct toxic effect on thyroid cells and reduces thyroid volume [33,34], which might lead to a decreased risk of thyroid cancer. However, a cross-sectional study found an increasing dose-response association between alcohol intake and the risk of thyroid enlargement [35].
3. Strengths and weaknesses of the current meta-analysis relative to other studies
To the best of our knowledge, this study is the most comprehensive meta-analysis of observational studies on the association between alcohol intake and the risk of thyroid cancer. Many epidemiological observational studies have reported inconsistent findings on this issue. In 2003, Mack et al. [11] conducted a pooled analysis of 14 case-control studies that indicated alcohol intake was associated with a reduced risk of thyroid. However, after adjustment for smoking, the reduced risk was not maintained. In 2012, a pooled analysis of five prospective cohort studies from the United States revealed that alcohol intake of more than seven drinks per week was inversely associated with the risk of thyroid cancer after adjustment for smoking [12]. Our meta-analysis involved 14 additional observational studies with cross-sectional, case-control, cohort studies as well as 20 case-control and cohort studies from those two pooled analyses. Four additional case-control studies have been conducted since the pooled analysis by Mack et al. [11] was published, most of which reported a protective effect of alcohol intake against the risk of cancer. Conversely, Xhaard et al. [28] showed an increased risk of thyroid cancer, although this increase was not significant. In the present study, a meta-analysis of 11 cohort studies (including six cohort studies published individually and five cohort studies from a pooled analysis) indicated that alcohol intake decreased the risk of thyroid cancer. Given that a cohort study generally shows a higher level of evidence than a case-control study, we believe that the results of the meta-analysis of cohort studies are more reliable than those from the meta-analysis of case-control studies.
When we performed subgroup meta-analyses by various factors, alcohol intake was consistently associated with a decreased risk of thyroid cancer, regardless of the type of thyroid cancer, sex, and amount of alcohol consumed. Even though alcohol intake had no association with thyroid cancer risk in the subgroup meta-analyses by study region (European and Asian regions), type of alcohol (wine, beer, or liquor), or methodological quality of study (low-quality studies), it is considered that those findings are attributable to the relatively small number of studies included in the analysis.
The subgroup meta-analyses by various factors within each study design showed that alcohol intake was consistently associated with a significantly decreased risk of thyroid cancer in both case-control and cohort studies, but a non-significantly decreased risk in cross-sectional studies. The non-significant findings in cross-sectional studies are also thought to be due to the small numbers of studies in the subgroup meta-analysis.
Choi et al. [27] conducted a study in Korea that showed an apparent increased risk of thyroid cancer in drinkers, unlike the other studies. We do not have any clear explanation for this finding. However, it should be noted that the study conducted by Choi et al. [27] had several limitations. Specifically, they determined whether respondents consumed alcohol simply based on asking “drinking or not,” not the amount of alcohol consumed. Moreover, they used a cross-sectional design, which is generally considered to provide a lower level of evidence than case-control studies or cohort studies. Conversely, a recent case-control study conducted in Korea reported that acute high-dose alcohol intake (151 g or more per event or on a single occasion) and long-term intake of alcohol for 31 or more years are associated with an increased risk of differentiated thyroid cancer [36]. Overall, further prospective studies are warranted to confirm the association between heavy drinking and the risk of thyroid cancer.
It should be noted that our study has several limitations. First, definitions for one drink of alcohol in each study included in the analysis were not identical. For example, Allen et al. used the total number of alcoholic drinks containing about 10 g of alcohol to categorize study participants into five groups [22], whereas Kitahara et al. [12] considered one drink to be equal to 14 g of alcohol. However, this discrepancy in the definitions for one drink would not lead to serious bias in our main findings on the association between alcohol intake and the risk of thyroid cancer. We were also not able to explain the exact reasons for the decreased risk of thyroid cancer associated with alcohol intake because we only included observational studies. Although we described possible mechanisms previously in the discussion section, further research is required to confirm these potential mechanisms. Moreover, we have limited information regarding alcohol intake during follow-up in cohort studies because information was collected only at one specific baseline point in time. Finally, due to a paucity of information in individual studies, we were unable to investigate the effects of alcohol intake on the risk of thyroid cancer according to types of alcohol beverages.
In conclusion, we found that alcohol intake was significantly associated with a decreased risk of thyroid cancer in the meta-analysis of observational epidemiological studies such as cross-sectional, case-control, and cohort studies. Moreover, cohort studies with a higher level of evidence consistently indicated this association. However, our findings should not be interpreted as indicating that alcohol intake can be recommended to prevent the development of thyroid cancer because alcohol intake is still a major risk factor for the development or aggravation of other various diseases such as several types of cancers (oropharyngeal cancer, laryngeal cancer, breast cancer, and colorectal cancer), liver diseases, and alcohol abuse.
The definite biological mechanism for the association between alcohol intake and thyroid cancer still remains uncertain. Further research is required to confirm the association between alcohol intake and the risk of cancer.

Conflict of interest relevant to this article was not reported.

Fig. 1.
Flow diagram of identification of relevant studies.
crt-2016-161f1.gif
Fig. 2.
Association between alcohol intake and risk of thyroid cancer in a fixed-effect model meta-analysis of observational studies (n=33) [11,12,16-29]. OR, odds ratio; RR, relative risk; CI, confidence interval. a)Fixed-effect model.
crt-2016-161f2.gif
Fig. 3.
Association between alcohol intake and risk of thyroid cancer in a fixed-effect model meta-analysis by type of study [11,16-29]. OR, odds ratio; RR, relative risk; CI, confidence interval. a)Fixed-effect model.
crt-2016-161f3.gif
Fig. 4.
Begg’s funnel plots and Egger’s test for identifying publication bias in meta-analysis of trials. OR, odds ratio; RR, relative risk; SE, standard error.
crt-2016-161f4.gif
Table 1.
General characteristics of the studies included in the final analysis
Study Type of study Country Years enrolled Population (sex, age) Type of thyroid cancer Definition of alcohol use (highest vs. lowest category) OR/RR (95% Cl) Adjusted variable
Takezaki et al. (1996) [16] Case-control study Japan 1988-1993 94 cases and 26,666 controls (women, 20-79 yr) Papillary or follicular thyroid cancer Sometimes or less/≥ 4 times/wk 0.70 (0.30-1.50) Age and year of visit
Rossing et al. (2000) [17] Case-control study United States 1988-1994 468 cases and 574 controls, (women, 18-64 yr) Papillary thyroid cancer 7 drinks/wk, vs. never, 1 drink: not specified 0.90 (0.50-1.40) Age, country of residence, race, marital status, education, history of radiation treatment, and smoking
fribarren et al. (2001) [18] Prospective cohort study United States 1964-1973 204,964 persons and 169 cases (men and women, 10-89 yr) All types of thyroid cancer ≥ 6 drinks/day vs. 1-2 drinks/day, 1 drink: not specified 0.95 (0.30-3.02) Age, sex, race, level of education, cigarette smoking, self-reported personal history, family history of thyroid disease, body mass index, weight gain, height, and occupational exposures
Mack et al. (2003) [11] Pooled analysis of 14 case-control studies United States, Europe, and Asia 1980-1997 2,725 cases and 4,776 controls (men and women, all ages) All types of thyroid cancer > 14 drinks/wk vs. none, 1 drink: one glass of wine or beer 0.90 (0.70-1.10) Study, sex, and age
Navarro Silvera et al. (2005) [19] Prospective cohort study Canada 1980-1985 89,835 persons and 169 cases (women, 40-59 yr) All types of thyroid cancer ≥ 10 g/day vs. none 0.84 (0.44-1.58) Age, education, BMI, and pack-years of smoking
Nagano et al. (2007) [21] Case-control study Japan 1970-1986 362 cases and 435 controls (men and women, > 75 yr) Papillary or follicular thyroid cancer Daily vs. never 0.59 (0.35-1.01) Family history of cancer, past history of goiter or thyroid nodule, and smoking history
Guignard et al. (2007) [20] Case-control study New Caledonia 1993-1999 332 cases and 412 controls (men and women ≥ 70 yr) Papillary or follicular thyroid cancer > 10 drinks/wk vs. never, 1 drink: an ordinary glass of any alcoholic beverage 0.64 (0.22-1.88) Age, year of reference, ethnic group, and number of pack-years
Allen et al. (2009) [22] Prospective cohort study United Kingdom 1996-2001 1,280,296 persons and 421 cases (women, average 55 yr) All types of thyroid cancer ≥ 15 drinks/wk vs. none, 1 drink: about 10 g of alcohol 0.54 (0.31-0.92) Age, region of residence, socioeconomic status,BMI, smoking, physical activity, use of oral contraceptives, and hormone replacement therapy
Meinhold et al. (2009) [23] Prospective cohort study United States 1995-1996 490,159 persons and 370 cases (men and women, 50-71 yr) All types of thyroid cancer ≥ 2 drinks/day vs. none, 1 drink: 12.96 g-13.93 g of ethanol according to type of alcoholic beverage 0.57 (0.36-0.89) Age, sex, race, education, smoking status, BMI, and family history of cancer
Meinhold et al. (2010) [24] Prospective cohort study United States 1983-2006 90,713 persons and 282 cases (men and women, all years) All types of thyroid cancer ≥ 7 drinks/wk vs. none, 1 drink: not specified 0.86 (0.54-1.39) Birth year, smoking, BMI, number of radiographs to the head and neck, and medical history of benign thyroid conditions
Han et al. (2011) [25] Cross-sectional study Korea 2009 2,000 persons and 263 cases (≥ 40 yr men, ≥ 30 yr women) All types of thyroid cancer ≥ 1 frequency/mo vs. none 0.61 (0.44-0.86) Age, residence, education, income, marital status, job, self-rated health, smoking, and vigorous exercise
Kabat et al. (2012) [26] Prospective cohort study United States 1993-1998 159,340 persons and 331 cases (women, 50-79 yr) All types of thyroid cancer ≥ 7 drinks/wk vs. none, 1 drink: not specified 0.66 (0.44-1.01) Age, education, pack-years of smoking, age of first pregnancy, age at menopause, hormone therapy, history of benign thyroid disease, observational study component/clinical trial component, and randomization status in CT
Kitahara et al. (2012) [12] Pooled analysis of five prospective cohort studies United States 1983-2009 746,097 persons and 1,003 cases (men and women, all years) All types of thyroid cancer ≥ 7 drinks/wk vs. none, 1 drink: 14 g of alcohol 0.72 (0.58-0.90) Age, sex, education, race, marital status, BMI, and smoking status
Choi et al. (2013) [27] Cross-sectional study Korea 2010-2011 12,276 persons and 71 cases (men and women, all years) All types of thyroid cancer Drinking vs. non-drinking 1.89 (1.08-3.32) Age, sex, weight, height, survey year, monthly household income, education, marital status, residential area, smoking, and physically active
Xhaard et al. (2014) [28] Case-control study French Polynesia 1981-2003 229 cases and 373 controls men and women, 10-62 yr) All types of thyroid cancer Regular alcohol consumption yes vs. no 1.20 (0.30-4.50) BMI, height, number of pregnancies, menopausal status, nuclear worker, family history of thyroid cancer, education, and irradiation of the neck
Stansifer et al. (2015) [29] Retrospective case-control study United States 2013 467 cases and 255 controls (men and women, ≥ 18 yr) All types of thyroid cancer Current drinker vs. never drinker 0.46 (0.29-0.73) None

OR, odd ratio; RR, relative risk; CI, confidence interval; BMI, body mass index; CT, computed tomography.

Table 2.
Methodological quality of studies included in the final analysis based on the Newcastle-Ottawa Scalea) for assessing the quality of case-control studies and cohort studies (n=12b))
Case-control studies (n=6)
Cohort studies (n=6)
Takezaki et al. (1996) [16] Rossing et al. (2000) [17] Nagano et al. (2007) [21] Guignard et al. (2007) [20] Xhaard et al. (2014) [28] Stansifer et al. (2015) [29] Iribarren et al. (2001) [18] Navarro Silvera et al. (2005) [19] Allen et al. (2009) [22] Meinhold et al. (2009) [23] Meinhold et al. (2010) [24] Rabat et al. (2012) [26]
Selection
 Adequate definition of cases 1 0 1 1 1 0 - - - - - -
 Representativeness of cases 1 1 1 1 1 1 - - - - - -
 Selection of controls 0 1 1 1 1 1 - - - - - -
 Definition of controls 1 0 1 1 0 1 - - - - - -
Comparability - - - - - -
 Control for important factor or additional factor 2 2 2 2 2 0 - - - - - -
Exposure
 Ascertainment of exposure (blinding) 0 0 1 0 0 0 - - - - - -
 Same method of ascertainment for participants 1 1 1 1 1 1 - - - - - -
 Nonresponse rate 0 0 1 1 0 0 - - - - - -
Total 6 5 9 8 6 4 - - - - - -
Selection
 Representativeness of the exposed cohort - - - 1 1 1 1 0 1
 Selection of the nonexposed cohort - - - - - - 1 1 1 1 1 1
 Ascertainment of exposure - - - - - - 0 0 0 0 0 0
 Outcome of interest was not present at start of study - - - - - - 0 1 1 1 1 0
Comparability
 Control for important factor or additional factor - - - - - - 2 2 2 2 2 2
Outcome
 Assessment of outcome - - - - - - 1 1 1 1 1 1
 Follow-up long enough for outcomes to occur - - - - - - 1 1 1 0 1 1
 Adequacy of follow-up of cohorts - - - - - - 0 0 0 0 0 1
Total - - - - - - 6 7 7 6 6 7

a) Each study can be awarded a maximum of one star for each numbered item within the selection and exposure categories, while a maximum of two stars can be given for the comparability category,

b) Two pooled studies [11,12] with 14 case-control studies and five cohort studies and a cross-sectional study were excluded from this assessment of methodological quality because no required information for the methodological assessment of each study was provided.

Table 3.
Association between alcohol intake and risk of thyroid cancer in subgroup meta-analyses
Factor No. of studies Summary OR or RR (95% CI) Heterogeneity, I2 (%) Model used
All [11,12,16-19] 33 0.74 (0.67-0.83) 38.6 Fixed-effect
Type of cancer
 All types of thyroid cancer [11,12,18,19,22-29] 29 0.74 (0.62-0.89) 52.3 Random-effects
 Papillary thyroid cancer [17,19,23,26] 4 0.70 (0.55-0.91) 0 Fixed-effect
 Papillary or follicular thyroid cancer [16,19-21] 4 0.68 (0.48-0.96) 0 Fixed-effect
Sex
 Female [16,17,19-26] 10 0.71 (0.60-0.84) 0 Fixed-effect
 Male [20,21,23-25] 5 0.57 (0.39-0.82) 0 Fixed-effect
Region
 America [12,17-19,23,24,26,29] 12 0.70 (0.60-0.81) 0 Fixed-effect
 Europe [22,28] 2 0.60 (0.36-1.00) 13.1 Fixed-effect
 Asia [16,21,25,27] 4 0.82 (0.48-1.42) 76.3 Random-effects
Amount of alcohol consumed (vs. never or rarely drink)
 ≤ 1-2 Drinks/wk [11,12,17,20,22-24,26] 25 0.89 (0.82-0.97) 0 Fixed-effect
 1-6 Drinks/wk [12,17,20,22-24,26] 11 0.83 (0.76-0.92) 15.5 Fixed-effect
 7-14 Drinks/wk [11,12,17,20-24,26,29] 27 0.75 (0.67-0.83) 15.0 Fixed-effect
 > 14 Drinks/wk [11,18,22,23] 17 0.80 (0.67-0.96) 30.2 Fixed-effect
Type of alcohol
 Wine [11,23] 15 0.95 (0.76-1.19) 0 Fixed-effect
 Beer [11,23] 15 0.63 (0.34-1.16) 66.3 Random-effects
 Wine and beer [11] 14 0.90 (0.70-1.10) NA Fixed-effect
 Liquor [23] 1 1.02 (0.68-1.53) NA Fixed-effect
Methodological quality
 High quality [19-22,26] 5 0.64 (0.50-0.82) 0 Fixed-effect
 Low quality [16-18,23,24,28,29] 7 0.68 (0.55-0.85) 6.7 Fixed-effect

OR, odd ratio; RR, relative risk; CI, confidence interval; NA, not applicable.

Table 4.
Association between alcohol intake and risk of thyroid cancer in subgroup meta-analyses of case-control studies
Factor No. of studies Summary OR or RR (95% CI) Heterogeneity, I2 (%) Model used
All  Low quality [11,16,17,20,21,28,29] 20 0.77 (0.65-0.92) 29.5 Fixed-effect
Type of cancer
 All types of thyroid cancer [11,28,29] 16 0.72 (0.41-1.25) 71.1 Random-effects
 Papillary thyroid cancer [17] 1 0.90 (0.50-1.40) NA Fixed-effect
 Papillary or follicular thyroid cancer [16,20,21] 3 0.62 (0.41-0.94) 0 Fixed-effect
Sex
 Female [16,17,20,21] 4 0.84 (0.59-1.19) 0 Fixed-effect
 Male [20,21] 2 0.35 (0.12-1.03) 0 Fixed-effect
Region
 America [17,29] 2 0.64 (0.33-1.23) 72.4 Fixed-effect
 Asia [16,21] 2 0.62 (0.40-0.97) 0 Fixed-effect
 Europe [28] 1 1.20 (0.30-4.50) NA Fixed-effect
Amount of alcohol consumed (vs. never or rarely drink)
 ≤ 1-2 Drinks/wk [11,17,20] 16 0.80 (0.68-0.93) 25.1 Fixed-effect
 1-6 Drinks/wk [17,20] 2 0.54 (0.39-0.75) 0 Fixed-effect
 7-14 Drinks/wk [11,17,20,21,29] 18 0.72 (0.52-0.98) 53.5 Random-effects
 > 14 Drinks/wk [11] 14 0.90 (0.70-1.10) NA Fixed-effect
Methodological quality
 High quality [20,21] 2 0.60 (0.37-0.96) 0 Fixed-effect
 Low quality [16,17,28,29] 4 0.65 (0.48-0.89) 33.5 Fixed-effect

OR, odd ratio; RR, relative risk; CI, confidence interval; NA, not applicable.

Table 5.
Association between alcohol intake and risk of thyroid cancer in subgroup meta-analyses of cohort studies
Factor No. of studies Summary OR or RR (95% CI) Heterogeneity, I2 (%) Model used
All [12,18,19,22-24,26] 11 0.70 (0.60-0.82) 0
Type of cancer
 All types of thyroid cancer [12,18,19,22-24,26] 11 0.70 (0.60-0.82) 0 Fixed-effect
 Papillary thyroid cancer [19,23,26] 3 0.65 (0.49-0.87) 0 Fixed-effect
 Papillary or follicular thyroid cancer [19] 1 0.84 (0.44-1.58) NA Fixed-effect
Sex
 Female [19,22-24,26] 5 0.67 (0.53-0.84) 0 Fixed-effect
 Male [23,24] 2 0.70 (0.43-1.14) 0 Fixed-effect
Region
 America [12,18,19,23,24,26] 10 0.72 (0.61-0.84) 0 Fixed-effect
 Europe [22] 1 0.54 (0.31-0.92) NA Fixed-effect
Amount of alcohol consumed (vs. never or rarely drink)
 ≤ 1-2 Drinks/wk [12,22-24,26] 9 0.93 (0.85-1.03) 0 Fixed-effect
 1-6 Drinks/wk [12,22-24,26] 9 0.87 (0.78-0.96) 0 Fixed-effect
 7-14 Drinks/wk [12,22-24,26] 9 0.71 (0.62-0.82) 0 Fixed-effect
 > 14 Drinks/wk [18,22,23] 3 0.66 (0.49-0.88) 0 Fixed-effect
Methodological quality
 High quality [19,22,26] 3 0.66 (0.49-0.88) 0 Fixed-effect
 Low quality [18,23,24] 3 0.71 (0.52-0.97) 0 Fixed-effect

OR, odd ratio; RR, relative risk; CI, confidence interval; NA, not applicable.

  • 1. Stewart BW, Wild CP. World cancer report 2014. Lyon: IARC Press; 2014.
  • 2. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212.ArticlePubMedPMCPDF
  • 3. Wartofsky L. Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure? Hormones (Athens). 2010;9:103–8. ArticlePubMed
  • 4. Mazzaferri EL. Managing thyroid microcarcinomas. Yonsei Med J. 2012;53:1–14. ArticlePubMedPMC
  • 5. Ron E, Schneider AB. Thyroid cancer. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006. p. 975–94.
  • 6. Thyroid cancer: what are the risk factors for thyroid cancer [Internet]. Atlanta, GA: American Cancer Society; 2016. [cited 2016 Jan 5]. Available from: http://www.cancer.org/cancer/thyroidcancer/detailedguide/thyroid-cancer-risk-factors
  • 7. Dal Maso L, Bosetti C, La Vecchia C, Franceschi S. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control. 2009;20:75–86. ArticlePubMed
  • 8. Truong T, Baron-Dubourdieu D, Rougier Y, Guenel P. Role of dietary iodine and cruciferous vegetables in thyroid cancer: a countrywide case-control study in New Caledonia. Cancer Causes Control. 2010;21:1183–92. ArticlePubMedPMC
  • 9. Kitahara CM, Platz EA, Freeman LE, Hsing AW, Linet MS, Park Y, et al. Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev. 2011;20:464–72. ArticlePubMedPMC
  • 10. Cho YA, Kim J. Thyroid cancer risk and smoking status: a meta-analysis. Cancer Causes Control. 2014;25:1187–95. ArticlePubMed
  • 11. Mack WJ, Preston-Martin S, Dal Maso L, Galanti R, Xiang M, Franceschi S, et al. A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control. 2003;14:773–85. ArticlePubMed
  • 12. Kitahara CM, Linet MS, Beane Freeman LE, Check DP, Church TR, Park Y, et al. Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes Control. 2012;23:1615–24. ArticlePubMedPMC
  • 13. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Internet]. Ottawa: The Ottwa Hospital, Research Institute; 2016. [cited 2016 Feb 2]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm
  • 14. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58. ArticlePubMed
  • 15. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88. ArticlePubMed
  • 16. Takezaki T, Hirose K, Inoue M, Hamajima N, Kuroishi T, Nakamura S, et al. Risk factors of thyroid cancer among women in Tokai, Japan. J Epidemiol. 1996;6:140–7. ArticlePubMed
  • 17. Rossing MA, Cushing KL, Voigt LF, Wicklund KG, Daling JR. Risk of papillary thyroid cancer in women in relation to smoking and alcohol consumption. Epidemiology. 2000;11:49–54. ArticlePubMed
  • 18. Iribarren C, Haselkorn T, Tekawa IS, Friedman GD. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer. 2001;93:745–50. ArticlePubMed
  • 19. Navarro Silvera SA, Miller AB, Rohan TE. Risk factors for thyroid cancer: a prospective cohort study. Int J Cancer. 2005;116:433–8. ArticlePubMed
  • 20. Guignard R, Truong T, Rougier Y, Baron-Dubourdieu D, Guenel P. Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia. Am J Epidemiol. 2007;166:1140–9. ArticlePubMedPMC
  • 21. Nagano J, Mabuchi K, Yoshimoto Y, Hayashi Y, Tsuda N, Land C, et al. A case-control study in Hiroshima and Nagasaki examining non-radiation risk factors for thyroid cancer. J Epidemiol. 2007;17:76–85. ArticlePubMedPMC
  • 22. Allen NE, Beral V, Casabonne D, Kan SW, Reeves GK, Brown A, et al. Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst. 2009;101:296–305. ArticlePubMed
  • 23. Meinhold CL, Park Y, Stolzenberg-Solomon RZ, Hollenbeck AR, Schatzkin A, Berrington de Gonzalez A. Alcohol intake and risk of thyroid cancer in the NIH-AARP Diet and Health Study. Br J Cancer. 2009;101:1630–4. ArticlePubMedPMC
  • 24. Meinhold CL, Ron E, Schonfeld SJ, Alexander BH, Freedman DM, Linet MS, et al. Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol. 2010;171:242–52. ArticlePubMedPMC
  • 25. Han MA, Choi KS, Lee HY, Kim Y, Jun JK, Park EC. Current status of thyroid cancer screening in Korea: results from a nationwide interview survey. Asian Pac J Cancer Prev. 2011;12:1657–63. PubMed
  • 26. Kabat GC, Kim MY, Wactawski-Wende J, Rohan TE. Smoking and alcohol consumption in relation to risk of thyroid cancer in postmenopausal women. Cancer Epidemiol. 2012;36:335–40. ArticlePubMed
  • 27. Choi SW, Ryu SY, Han MA, Park J. The association between the socioeconomic status and thyroid cancer prevalence: based on the Korean National Health and Nutrition Examination Survey 2010-2011. J Korean Med Sci. 2013;28:1734–40. ArticlePubMedPMC
  • 28. Xhaard C, Ren Y, Clero E, Maillard S, Brindel P, Rachedi F, et al. Differentiated thyroid carcinoma risk factors in French Polynesia. Asian Pac J Cancer Prev. 2014;15:2675–80. ArticlePubMed
  • 29. Stansifer KJ, Guynan JF, Wachal BM, Smith RB. Modifiable risk factors and thyroid cancer. Otolaryngol Head Neck Surg. 2015;152:432–7. ArticlePubMed
  • 30. Boelaert K. The association between serum TSH concentration and thyroid cancer. Endocr Relat Cancer. 2009;16:1065–72. ArticlePubMed
  • 31. Zoeller RT, Fletcher DL, Simonyl A, Rudeen PK. Chronic ethanol treatment reduces the responsiveness of the hypothalamic- pituitary-thyroid axis to central stimulation. Alcohol Clin Exp Res. 1996;20:954–60. ArticlePubMed
  • 32. Balhara YP, Deb KS. Impact of alcohol use on thyroid function. Indian J Endocrinol Metab. 2013;17:580–7. ArticlePubMedPMC
  • 33. Hegedus L, Rasmussen N, Ravn V, Kastrup J, Krogsgaard K, Aldershvile J. Independent effects of liver disease and chronic alcoholism on thyroid function and size: the possibility of a toxic effect of alcohol on the thyroid gland. Metabolism. 1988;37:229–33. ArticlePubMed
  • 34. Knudsen N, Bulow I, Laurberg P, Perrild H, Ovesen L, Jorgensen T. Alcohol consumption is associated with reduced prevalence of goitre and solitary thyroid nodules. Clin Endocrinol (Oxf). 2001;55:41–6. ArticlePubMed
  • 35. Valeix P, Faure P, Bertrais S, Vergnaud AC, Dauchet L, Hercberg S. Effects of light to moderate alcohol consumption on thyroid volume and thyroid function. Clin Endocrinol (Oxf). 2008;68:988–95. ArticlePubMed
  • 36. Hwang Y, Lee KE, Weiderpass E, Park YJ, Chai YJ, Kwon H, et al. Acute high-dose and chronic lifetime exposure to alcohol consumption and differentiated thyroid cancer: T-CALOS Korea. PLoS One. 2016;11:e0151562ArticlePubMedPMC

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Associations Between Obesity and Risk of Thyroid Cancer: A Meta-Analysis of Cohort Studies
      Urfa Khairatun Hisan, Seung-Kwon Myung, Giap Viet Nguyen
      Nutrition and Cancer.2025; 77(2): 288.     CrossRef
    • Nongenetic risk factors for thyroid cancer: an umbrella review of evidence
      Ge Peng, Xiaohui Pan, Ziwei Ye, Xianyanling Yi, Qingxing Xie, Xinyi Zhang, Nanwei Tong
      Endocrine.2025;[Epub]     CrossRef
    • Relationship of modifiable risk factors with the incidence of thyroid cancer: a worldwide study
      Zahra Maleki, Jafar Hassanzadeh, Haleh Ghaem
      BMC Research Notes.2025;[Epub]     CrossRef
    • Cigarette Smoking, Alcohol Consumption, and the Risk of Thyroid Cancer in Japan: The Japan Public Health Center–Based Prospective Study
      Marina Tanitame, Manami Inoue, Taiki Yamaji, Motoki Iwasaki, Shoichiro Tsugane, Norie Sawada
      Cancer Epidemiology, Biomarkers & Prevention.2025; 34(2): 317.     CrossRef
    • Predicting central lymph node metastasis in papillary thyroid carcinoma combined with Hashimoto's thyroiditis: a preoperative study
      Pengwei Lou, Yuting Huang, Hui Li, Feng Zhao, Jiabo Xu, Kai Wang
      BMC Cancer.2025;[Epub]     CrossRef
    • Prevalence of thyroid nodule and relationship with physiological and psychosocial factors among adults in Zhejiang Province, China: a baseline survey of a cohort study
      Xueqing Li, Zhijian Chen, Lizhi Wu, Pengchen Tu, Zhe Mo, Mingluan Xing
      BMC Public Health.2024;[Epub]     CrossRef
    • The influence of nutrition in nodular thyroid pathology: a systematic review
      Vanessa Neto, Catarina Leitão, Marta Estrela, Margarida Fardilha, Maria Teresa Herdeiro, Alexandra Nunes
      Critical Reviews in Food Science and Nutrition.2024; : 1.     CrossRef
    • Alcohol consumption and its association with cancer, cardiovascular, liver and brain diseases: a systematic review of Mendelian randomization studies
      Naouras Bouajila, Cloé Domenighetti, Henri-Jean Aubin, Mickael Naassila
      Frontiers in Epidemiology.2024;[Epub]     CrossRef
    • The Correlation Between Biological Markers and Prognosis in Thyroid Cancer
      Rami Hajjar, Ciprian Duta, Ionut Flaviu Faur, Catalin Prodan-Barbulescu, Hadi Alhajjar, Stelian Pantea
      Biomedicines.2024; 12(12): 2826.     CrossRef
    • Sweetened beverages are associated with a higher risk of differentiated thyroid cancer in the EPIC cohort: a dietary pattern approach
      Raul Zamora-Ros, Valerie Cayssials, Ramon Clèries, Maria Torrents, Graham Byrnes, Elisabete Weiderpass, Maria Sandström, Martin Almquist, Marie-Christine Boutron-Ruault, Anne Tjønneland, Cecilie Kyrø, Verena A. Katzke, Charlotte Le Cornet, Giovanna Masala
      European Journal of Nutrition.2023; 62(1): 105.     CrossRef
    • Molecular Testing Results for Indeterminate Thyroid Nodules and Social Habits
      Hui Zheng, John F. Whitney, Victoria Lai
      Journal of Surgical Research.2023; 284: 245.     CrossRef
    • Smoking and alcohol consumption with the risk of 11 common otolaryngological diseases: a bidirectional Mendelian randomization
      Xu Wang, Yuewei Bi, Guangping Liu, Wei Wang, Hualei Cui
      European Archives of Oto-Rhino-Laryngology.2023; 280(12): 5615.     CrossRef
    • Will metformin use lead to a decreased risk of thyroid cancer? A systematic review and meta-analyses
      Hailong Li, Yue Chen, Lei Hu, Wenzhi Yang, Zongshi Gao, Mengqing Liu, Hui Tao, Jie Li
      European Journal of Medical Research.2023;[Epub]     CrossRef
    • Cancer risk based on alcohol consumption levels: a comprehensive systematic review and meta-analysis
      Seunghee Jun, Hyunjin Park, Ui-Jeong Kim, Eun Jeong Choi, Hye Ah Lee, Bomi Park, Soon Young Lee, Sun Ha Jee, Hyesook Park
      Epidemiology and Health.2023; 45: e2023092.     CrossRef
    • Adapted dietary inflammatory index and differentiated thyroid carcinoma risk in two French population-based case–control studies
      Lucie Lécuyer, Nasser Laouali, Mariem Hajji-Louati, Melanie Paquet, Vincent Souchard, Mojgan Karimi, Claire Schvartz, Anne-Valérie Guizard, Constance Xhaard, Carole Rubino, Yan Ren, Françoise Borson-Chazot, Elisabeth Adjadj, Emilie Cordina-Duverger, Flore
      European Journal of Nutrition.2022; 61(2): 1097.     CrossRef
    • Association between Thyroid Cancer and Breast Cancer: Two Longitudinal Follow-Up Studies Using a National Health Screening Cohort
      Young Ju Jin, Mi Jung Kwon, Ji Hee Kim, Joo-Hee Kim, Hyo Geun Choi
      Journal of Personalized Medicine.2022; 12(2): 133.     CrossRef
    • Smoking, Alcohol Consumption, and the Risk of Thyroid Cancer: A Population-Based Korean Cohort Study of 10 Million People
      Yohwan Yeo, Dong Wook Shin, Kyungdo Han, Dahye Kim, Tae Hyuk Kim, Sohyun Chun, Su-Min Jeong, Yun-Mi Song
      Thyroid.2022; 32(4): 440.     CrossRef
    • Alcohol and Health Outcomes: An Umbrella Review of Meta-Analyses Base on Prospective Cohort Studies
      Lixian Zhong, Weiwei Chen, Tonghua Wang, Qiuting Zeng, Leizhen Lai, Junlong Lai, Junqin Lin, Shaohui Tang
      Frontiers in Public Health.2022;[Epub]     CrossRef
    • Inflammatory potential of the diet and association with risk of differentiated thyroid cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
      Lucie Lécuyer, Nasser Laouali, Laure Dossus, Nitin Shivappa, James R. Hébert, Antonio Agudo, Anne Tjonneland, Jytte Halkjaer, Kim Overvad, Verena A. Katzke, Charlotte Le Cornet, Matthias B. Schulze, Franziska Jannasch, Domenico Palli, Claudia Agnoli, Rosa
      European Journal of Nutrition.2022; 61(7): 3625.     CrossRef
    • Are “Bad Habits” Good? The Relationships Between Smoking, Alcohol Use, and Thyroid Cancer
      Alex Tessnow
      Clinical Thyroidology.2022; 34(7): 309.     CrossRef
    • Adherence to mediterranean diet and the risk of differentiated thyroid cancer in a European cohort: The EPIC study
      Fjorida Llaha, Valerie Cayssials, Marta Farràs, Antonio Agudo, Maria Sandström, Anne Kirstine Eriksen, Anne Tjønneland, Marie-Christine Boutron-Ruault, Nasser Laouali, Thérèse Truong, Charlotte Le Cornet, Verena Katzke, Matthias Schulze, Domenico Palli, V
      Frontiers in Nutrition.2022;[Epub]     CrossRef
    • Multiethnic genome‐wide association study of differentiated thyroid cancer in the EPITHYR consortium
      Thérèse Truong, Fabienne Lesueur, Pierre‐Emmanuel Sugier, Julie Guibon, Constance Xhaard, Mojgan Karimi, Om Kulkarni, Elise A. Lucotte, Delphine Bacq‐Daian, Anne Boland‐Auge, Claire Mulot, Pierre Laurent‐Puig, Claire Schvartz, Anne‐Valérie Guizard, Yan Re
      International Journal of Cancer.2021; 148(12): 2935.     CrossRef
    • Association of Polygenetic Risk Scores Related to Cell Differentiation and Inflammation with Thyroid Cancer Risk and Genetic Interaction with Dietary Intake
      Sang Shin Song, ShaoKai Huang, Sunmin Park
      Cancers.2021; 13(7): 1510.     CrossRef
    • Incidence and mortality from thyroid cancer in Latin America
      Fábia Cheyenne Gomes de Morais Fernandes, Dyego Leandro Bezerra de Souza, Maria Paula Curado, Talita Araujo de Souza, Arthur de Almeida Medeiros, Isabelle Ribeiro Barbosa
      Tropical Medicine & International Health.2021; 26(7): 800.     CrossRef
    • Trends in Childhood Thyroid Cancer incidence in Korea and Its Potential Risk Factors
      Jun Park, Hyunju Park, Tae Hyuk Kim, Sun Wook Kim, Hye Won Jang, Jae Hoon Chung
      Frontiers in Endocrinology.2021;[Epub]     CrossRef
    • Changes in Smoking, Alcohol Consumption, and the Risk of Thyroid Cancer: A Population-Based Korean Cohort Study
      Yohwan Yeo, Kyungdo Han, Dong-Wook Shin, Dahye Kim, Su-Min Jeong, Sohyun Chun, In-Young Choi, Keun-Hye Jeon, Tae-Hyuk Kim
      Cancers.2021; 13(10): 2343.     CrossRef
    • Der Tumormarker Thyreoglobulin
      K. Passek, N. Zulauf, M. H. Bendels, D. Quarcoo, G. M. Oremek
      Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie.2020; 70(1): 40.     CrossRef
    • Withdrawn: Smoking, alcohol consumption, and the risk of thyroid cancer: a population-based Korean cohort study of 10 million people
      Yohwan Yeo, Dong Wook Shin, Kyung-Do Han, Dahye Kim, Tae Hyuk Kim, Sohyun Chun, Sumin Jeong, Yun-Mi Song
      Thyroid.2020;[Epub]     CrossRef
    • Association between Family Histories of Thyroid Cancer and Thyroid Cancer Incidence: A Cross-Sectional Study Using the Korean Genome and Epidemiology Study Data
      Soo-Hwan Byun, Chanyang Min, Hyo-Geun Choi, Seok-Jin Hong
      Genes.2020; 11(9): 1039.     CrossRef
    • A national database analysis for factors associated with thyroid cancer occurrence
      Joon-Hyop Lee, Sora Youn, Sohee Jung, Kwangsoo Kim, Young Jun Chai, Yoo Seung Chung, Won Seo Park, Kyu Eun Lee, Ka Hee Yi
      Scientific Reports.2020;[Epub]     CrossRef
    • Obesity is positively related and tobacco smoking and alcohol consumption are negatively related to an increased risk of thyroid cancer
      Soo-Youn An, So Young Kim, Dong Jun Oh, Chanyang Min, Songyoung Sim, Hyo Geun Choi
      Scientific Reports.2020;[Epub]     CrossRef
    • Human milk as a protective factor for bronchopulmonary dysplasia: a systematic review and meta-analysis
      Jinglan Huang, Li Zhang, Jun Tang, Jing Shi, Yi Qu, Tao Xiong, Dezhi Mu
      Archives of Disease in Childhood - Fetal and Neonatal Edition.2019; 104(2): F128.     CrossRef
    • Leukocyte Mitochondrial DNA Copy Number and Risk of Thyroid Cancer: A Two-Stage Case-Control Study
      Jian Zheng, Ning-hua Cui, Shuai Zhang, Xue-bin Wang, Liang Ming
      Frontiers in Endocrinology.2019;[Epub]     CrossRef
    • Contemporary Debates in Adult Papillary Thyroid Cancer Management
      Donald S A McLeod, Ling Zhang, Cosimo Durante, David S Cooper
      Endocrine Reviews.2019; 40(6): 1481.     CrossRef
    • Low expression of ryanodine receptor 2 is associated with poor prognosis in thyroid carcinoma
      Nizhen Xu, Deguang Zhang, Jian Chen, Gaofei He, Li Gao
      Oncology Letters.2019;[Epub]     CrossRef
    • A Linkage Between Thyroid and Breast Cancer: A Common Etiology?
      Eric L. Bolf, Brian L. Sprague, Frances E. Carr
      Cancer Epidemiology, Biomarkers & Prevention.2019; 28(4): 643.     CrossRef
    • Interaction between alcohol consumption and methylenetetrahydrofolate reductase polymorphisms in thyroid cancer risk: National Cancer Center cohort in Korea
      Sarah Yang, Jeonghee Lee, Yoon Park, Eun Kyung Lee, Yul Hwangbo, Junsun Ryu, Joohon Sung, Jeongseon Kim
      Scientific Reports.2018;[Epub]     CrossRef
    • Alcohol consumption and risk of hematological malignancies: A meta‐analysis of prospective studies
      Theodora Psaltopoulou, Theodoros N. Sergentanis, Ioannis Ntanasis‐Stathopoulos, Ioannis‐Georgios Tzanninis, Diamantis I. Tsilimigras, Meletios A. Dimopoulos
      International Journal of Cancer.2018; 143(3): 486.     CrossRef
    • Light Alcohol Drinking and Risk of Cancer: A Meta-Analysis of Cohort Studies
      Yoon-Jung Choi, Seung-Kwon Myung, Ji-Ho Lee
      Cancer Research and Treatment.2018; 50(2): 474.     CrossRef
    • Thyroid Cancer Epidemiology in South Spain: a population-based time trend study
      Elena Salamanca-Fernández, Miguel Rodriguez-Barranco, Yoe-Ling Chang-Chan, Daniel Redondo-Sánchez, Santiago Domínguez-López, Eloísa Bayo, Dariusz Narankiewicz, José Expósito, María José Sánchez
      Endocrine.2018; 62(2): 423.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Alcohol Intake and Risk of Thyroid Cancer: A Meta-Analysis of Observational Studies
      Cancer Res Treat. 2017;49(2):534-547.   Published online July 7, 2016
      Close
    • XML DownloadXML Download
    Alcohol Intake and Risk of Thyroid Cancer: A Meta-Analysis of Observational Studies
    Image Image Image Image
    Fig. 1. Flow diagram of identification of relevant studies.
    Fig. 2. Association between alcohol intake and risk of thyroid cancer in a fixed-effect model meta-analysis of observational studies (n=33) [11,12,16-29]. OR, odds ratio; RR, relative risk; CI, confidence interval. a)Fixed-effect model.
    Fig. 3. Association between alcohol intake and risk of thyroid cancer in a fixed-effect model meta-analysis by type of study [11,16-29]. OR, odds ratio; RR, relative risk; CI, confidence interval. a)Fixed-effect model.
    Fig. 4. Begg’s funnel plots and Egger’s test for identifying publication bias in meta-analysis of trials. OR, odds ratio; RR, relative risk; SE, standard error.
    Alcohol Intake and Risk of Thyroid Cancer: A Meta-Analysis of Observational Studies
    Study Type of study Country Years enrolled Population (sex, age) Type of thyroid cancer Definition of alcohol use (highest vs. lowest category) OR/RR (95% Cl) Adjusted variable
    Takezaki et al. (1996) [16] Case-control study Japan 1988-1993 94 cases and 26,666 controls (women, 20-79 yr) Papillary or follicular thyroid cancer Sometimes or less/≥ 4 times/wk 0.70 (0.30-1.50) Age and year of visit
    Rossing et al. (2000) [17] Case-control study United States 1988-1994 468 cases and 574 controls, (women, 18-64 yr) Papillary thyroid cancer 7 drinks/wk, vs. never, 1 drink: not specified 0.90 (0.50-1.40) Age, country of residence, race, marital status, education, history of radiation treatment, and smoking
    fribarren et al. (2001) [18] Prospective cohort study United States 1964-1973 204,964 persons and 169 cases (men and women, 10-89 yr) All types of thyroid cancer ≥ 6 drinks/day vs. 1-2 drinks/day, 1 drink: not specified 0.95 (0.30-3.02) Age, sex, race, level of education, cigarette smoking, self-reported personal history, family history of thyroid disease, body mass index, weight gain, height, and occupational exposures
    Mack et al. (2003) [11] Pooled analysis of 14 case-control studies United States, Europe, and Asia 1980-1997 2,725 cases and 4,776 controls (men and women, all ages) All types of thyroid cancer > 14 drinks/wk vs. none, 1 drink: one glass of wine or beer 0.90 (0.70-1.10) Study, sex, and age
    Navarro Silvera et al. (2005) [19] Prospective cohort study Canada 1980-1985 89,835 persons and 169 cases (women, 40-59 yr) All types of thyroid cancer ≥ 10 g/day vs. none 0.84 (0.44-1.58) Age, education, BMI, and pack-years of smoking
    Nagano et al. (2007) [21] Case-control study Japan 1970-1986 362 cases and 435 controls (men and women, > 75 yr) Papillary or follicular thyroid cancer Daily vs. never 0.59 (0.35-1.01) Family history of cancer, past history of goiter or thyroid nodule, and smoking history
    Guignard et al. (2007) [20] Case-control study New Caledonia 1993-1999 332 cases and 412 controls (men and women ≥ 70 yr) Papillary or follicular thyroid cancer > 10 drinks/wk vs. never, 1 drink: an ordinary glass of any alcoholic beverage 0.64 (0.22-1.88) Age, year of reference, ethnic group, and number of pack-years
    Allen et al. (2009) [22] Prospective cohort study United Kingdom 1996-2001 1,280,296 persons and 421 cases (women, average 55 yr) All types of thyroid cancer ≥ 15 drinks/wk vs. none, 1 drink: about 10 g of alcohol 0.54 (0.31-0.92) Age, region of residence, socioeconomic status,BMI, smoking, physical activity, use of oral contraceptives, and hormone replacement therapy
    Meinhold et al. (2009) [23] Prospective cohort study United States 1995-1996 490,159 persons and 370 cases (men and women, 50-71 yr) All types of thyroid cancer ≥ 2 drinks/day vs. none, 1 drink: 12.96 g-13.93 g of ethanol according to type of alcoholic beverage 0.57 (0.36-0.89) Age, sex, race, education, smoking status, BMI, and family history of cancer
    Meinhold et al. (2010) [24] Prospective cohort study United States 1983-2006 90,713 persons and 282 cases (men and women, all years) All types of thyroid cancer ≥ 7 drinks/wk vs. none, 1 drink: not specified 0.86 (0.54-1.39) Birth year, smoking, BMI, number of radiographs to the head and neck, and medical history of benign thyroid conditions
    Han et al. (2011) [25] Cross-sectional study Korea 2009 2,000 persons and 263 cases (≥ 40 yr men, ≥ 30 yr women) All types of thyroid cancer ≥ 1 frequency/mo vs. none 0.61 (0.44-0.86) Age, residence, education, income, marital status, job, self-rated health, smoking, and vigorous exercise
    Kabat et al. (2012) [26] Prospective cohort study United States 1993-1998 159,340 persons and 331 cases (women, 50-79 yr) All types of thyroid cancer ≥ 7 drinks/wk vs. none, 1 drink: not specified 0.66 (0.44-1.01) Age, education, pack-years of smoking, age of first pregnancy, age at menopause, hormone therapy, history of benign thyroid disease, observational study component/clinical trial component, and randomization status in CT
    Kitahara et al. (2012) [12] Pooled analysis of five prospective cohort studies United States 1983-2009 746,097 persons and 1,003 cases (men and women, all years) All types of thyroid cancer ≥ 7 drinks/wk vs. none, 1 drink: 14 g of alcohol 0.72 (0.58-0.90) Age, sex, education, race, marital status, BMI, and smoking status
    Choi et al. (2013) [27] Cross-sectional study Korea 2010-2011 12,276 persons and 71 cases (men and women, all years) All types of thyroid cancer Drinking vs. non-drinking 1.89 (1.08-3.32) Age, sex, weight, height, survey year, monthly household income, education, marital status, residential area, smoking, and physically active
    Xhaard et al. (2014) [28] Case-control study French Polynesia 1981-2003 229 cases and 373 controls men and women, 10-62 yr) All types of thyroid cancer Regular alcohol consumption yes vs. no 1.20 (0.30-4.50) BMI, height, number of pregnancies, menopausal status, nuclear worker, family history of thyroid cancer, education, and irradiation of the neck
    Stansifer et al. (2015) [29] Retrospective case-control study United States 2013 467 cases and 255 controls (men and women, ≥ 18 yr) All types of thyroid cancer Current drinker vs. never drinker 0.46 (0.29-0.73) None
    Case-control studies (n=6)
    Cohort studies (n=6)
    Takezaki et al. (1996) [16] Rossing et al. (2000) [17] Nagano et al. (2007) [21] Guignard et al. (2007) [20] Xhaard et al. (2014) [28] Stansifer et al. (2015) [29] Iribarren et al. (2001) [18] Navarro Silvera et al. (2005) [19] Allen et al. (2009) [22] Meinhold et al. (2009) [23] Meinhold et al. (2010) [24] Rabat et al. (2012) [26]
    Selection
     Adequate definition of cases 1 0 1 1 1 0 - - - - - -
     Representativeness of cases 1 1 1 1 1 1 - - - - - -
     Selection of controls 0 1 1 1 1 1 - - - - - -
     Definition of controls 1 0 1 1 0 1 - - - - - -
    Comparability - - - - - -
     Control for important factor or additional factor 2 2 2 2 2 0 - - - - - -
    Exposure
     Ascertainment of exposure (blinding) 0 0 1 0 0 0 - - - - - -
     Same method of ascertainment for participants 1 1 1 1 1 1 - - - - - -
     Nonresponse rate 0 0 1 1 0 0 - - - - - -
    Total 6 5 9 8 6 4 - - - - - -
    Selection
     Representativeness of the exposed cohort - - - 1 1 1 1 0 1
     Selection of the nonexposed cohort - - - - - - 1 1 1 1 1 1
     Ascertainment of exposure - - - - - - 0 0 0 0 0 0
     Outcome of interest was not present at start of study - - - - - - 0 1 1 1 1 0
    Comparability
     Control for important factor or additional factor - - - - - - 2 2 2 2 2 2
    Outcome
     Assessment of outcome - - - - - - 1 1 1 1 1 1
     Follow-up long enough for outcomes to occur - - - - - - 1 1 1 0 1 1
     Adequacy of follow-up of cohorts - - - - - - 0 0 0 0 0 1
    Total - - - - - - 6 7 7 6 6 7
    Factor No. of studies Summary OR or RR (95% CI) Heterogeneity, I2 (%) Model used
    All [11,12,16-19] 33 0.74 (0.67-0.83) 38.6 Fixed-effect
    Type of cancer
     All types of thyroid cancer [11,12,18,19,22-29] 29 0.74 (0.62-0.89) 52.3 Random-effects
     Papillary thyroid cancer [17,19,23,26] 4 0.70 (0.55-0.91) 0 Fixed-effect
     Papillary or follicular thyroid cancer [16,19-21] 4 0.68 (0.48-0.96) 0 Fixed-effect
    Sex
     Female [16,17,19-26] 10 0.71 (0.60-0.84) 0 Fixed-effect
     Male [20,21,23-25] 5 0.57 (0.39-0.82) 0 Fixed-effect
    Region
     America [12,17-19,23,24,26,29] 12 0.70 (0.60-0.81) 0 Fixed-effect
     Europe [22,28] 2 0.60 (0.36-1.00) 13.1 Fixed-effect
     Asia [16,21,25,27] 4 0.82 (0.48-1.42) 76.3 Random-effects
    Amount of alcohol consumed (vs. never or rarely drink)
     ≤ 1-2 Drinks/wk [11,12,17,20,22-24,26] 25 0.89 (0.82-0.97) 0 Fixed-effect
     1-6 Drinks/wk [12,17,20,22-24,26] 11 0.83 (0.76-0.92) 15.5 Fixed-effect
     7-14 Drinks/wk [11,12,17,20-24,26,29] 27 0.75 (0.67-0.83) 15.0 Fixed-effect
     > 14 Drinks/wk [11,18,22,23] 17 0.80 (0.67-0.96) 30.2 Fixed-effect
    Type of alcohol
     Wine [11,23] 15 0.95 (0.76-1.19) 0 Fixed-effect
     Beer [11,23] 15 0.63 (0.34-1.16) 66.3 Random-effects
     Wine and beer [11] 14 0.90 (0.70-1.10) NA Fixed-effect
     Liquor [23] 1 1.02 (0.68-1.53) NA Fixed-effect
    Methodological quality
     High quality [19-22,26] 5 0.64 (0.50-0.82) 0 Fixed-effect
     Low quality [16-18,23,24,28,29] 7 0.68 (0.55-0.85) 6.7 Fixed-effect
    Factor No. of studies Summary OR or RR (95% CI) Heterogeneity, I2 (%) Model used
    All  Low quality [11,16,17,20,21,28,29] 20 0.77 (0.65-0.92) 29.5 Fixed-effect
    Type of cancer
     All types of thyroid cancer [11,28,29] 16 0.72 (0.41-1.25) 71.1 Random-effects
     Papillary thyroid cancer [17] 1 0.90 (0.50-1.40) NA Fixed-effect
     Papillary or follicular thyroid cancer [16,20,21] 3 0.62 (0.41-0.94) 0 Fixed-effect
    Sex
     Female [16,17,20,21] 4 0.84 (0.59-1.19) 0 Fixed-effect
     Male [20,21] 2 0.35 (0.12-1.03) 0 Fixed-effect
    Region
     America [17,29] 2 0.64 (0.33-1.23) 72.4 Fixed-effect
     Asia [16,21] 2 0.62 (0.40-0.97) 0 Fixed-effect
     Europe [28] 1 1.20 (0.30-4.50) NA Fixed-effect
    Amount of alcohol consumed (vs. never or rarely drink)
     ≤ 1-2 Drinks/wk [11,17,20] 16 0.80 (0.68-0.93) 25.1 Fixed-effect
     1-6 Drinks/wk [17,20] 2 0.54 (0.39-0.75) 0 Fixed-effect
     7-14 Drinks/wk [11,17,20,21,29] 18 0.72 (0.52-0.98) 53.5 Random-effects
     > 14 Drinks/wk [11] 14 0.90 (0.70-1.10) NA Fixed-effect
    Methodological quality
     High quality [20,21] 2 0.60 (0.37-0.96) 0 Fixed-effect
     Low quality [16,17,28,29] 4 0.65 (0.48-0.89) 33.5 Fixed-effect
    Factor No. of studies Summary OR or RR (95% CI) Heterogeneity, I2 (%) Model used
    All [12,18,19,22-24,26] 11 0.70 (0.60-0.82) 0
    Type of cancer
     All types of thyroid cancer [12,18,19,22-24,26] 11 0.70 (0.60-0.82) 0 Fixed-effect
     Papillary thyroid cancer [19,23,26] 3 0.65 (0.49-0.87) 0 Fixed-effect
     Papillary or follicular thyroid cancer [19] 1 0.84 (0.44-1.58) NA Fixed-effect
    Sex
     Female [19,22-24,26] 5 0.67 (0.53-0.84) 0 Fixed-effect
     Male [23,24] 2 0.70 (0.43-1.14) 0 Fixed-effect
    Region
     America [12,18,19,23,24,26] 10 0.72 (0.61-0.84) 0 Fixed-effect
     Europe [22] 1 0.54 (0.31-0.92) NA Fixed-effect
    Amount of alcohol consumed (vs. never or rarely drink)
     ≤ 1-2 Drinks/wk [12,22-24,26] 9 0.93 (0.85-1.03) 0 Fixed-effect
     1-6 Drinks/wk [12,22-24,26] 9 0.87 (0.78-0.96) 0 Fixed-effect
     7-14 Drinks/wk [12,22-24,26] 9 0.71 (0.62-0.82) 0 Fixed-effect
     > 14 Drinks/wk [18,22,23] 3 0.66 (0.49-0.88) 0 Fixed-effect
    Methodological quality
     High quality [19,22,26] 3 0.66 (0.49-0.88) 0 Fixed-effect
     Low quality [18,23,24] 3 0.71 (0.52-0.97) 0 Fixed-effect
    Table 1. General characteristics of the studies included in the final analysis

    OR, odd ratio; RR, relative risk; CI, confidence interval; BMI, body mass index; CT, computed tomography.

    Table 2. Methodological quality of studies included in the final analysis based on the Newcastle-Ottawa Scalea) for assessing the quality of case-control studies and cohort studies (n=12b))

    Each study can be awarded a maximum of one star for each numbered item within the selection and exposure categories, while a maximum of two stars can be given for the comparability category,

    Two pooled studies [11,12] with 14 case-control studies and five cohort studies and a cross-sectional study were excluded from this assessment of methodological quality because no required information for the methodological assessment of each study was provided.

    Table 3. Association between alcohol intake and risk of thyroid cancer in subgroup meta-analyses

    OR, odd ratio; RR, relative risk; CI, confidence interval; NA, not applicable.

    Table 4. Association between alcohol intake and risk of thyroid cancer in subgroup meta-analyses of case-control studies

    OR, odd ratio; RR, relative risk; CI, confidence interval; NA, not applicable.

    Table 5. Association between alcohol intake and risk of thyroid cancer in subgroup meta-analyses of cohort studies

    OR, odd ratio; RR, relative risk; CI, confidence interval; NA, not applicable.


    Cancer Res Treat : Cancer Research and Treatment
    Close layer
    TOP